Follicular Lymphoma International Prognostic Index (FLIPI)
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | BIO-FL-FLIPI |
|---|---|
| Type | Biomarker |
| Aliases | FLIPIFLIPI scoreFLIPI2Прогностичний індекс при фолікулярній лімфомі (FLIPI) |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | None declared |
| Sources | SRC-NCCN-BCELL-2025 |
Biomarker Facts
| Biomarker type | composite_score |
|---|---|
| Measurement | Method5-variable score: age >60, Hb <12 g/dL, LDH >ULN, stage III-IV, ≥5 nodal areas Unitsscore 0-5 (low / int / high) |
| Related biomarkers | None declared |
Notes
Risk groups: 0-1 low (10y OS ~70%); 2 int (~50%); ≥3 high (~35%). FLIPI2 incorporates Hb + β2M + LDH + bone marrow + longest mass diameter — slightly better-discriminating but used less commonly. Informational stratification for prognosis counsel; does NOT directly drive 1L treatment choice (GELF criteria do that).
Used By
Indications
IND-FL-1L-BR- IND-FL-1L-BRIND-FL-1L-RCHOP-AGGRESSIVE- IND-FL-1L-RCHOP-AGGRESSIVEIND-FL-1L-WATCH- IND-FL-1L-WATCH
Questionnaires
QUEST-FL-1L-STUB- Follicular Lymphoma — first line